Kyphoplasty Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

The Global Kyphoplasty Market is projected to expand from USD 734.85 Million in 2025 to USD 1.07 billion by 2031, reflecting a compound annual growth rate of 6.51%. Kyphoplasty involves a minimally invasive technique wherein a specialized balloon is inserted into a fractured vertebra to create a cavity, which is then filled with bone cement to restore height and stability. Market growth is primarily driven by a globally aging population and a corresponding rise in osteoporosis, which increases the incidence of spinal fractures. Additionally, the shift toward minimally invasive options over traditional open surgeries continues to gain traction due to advantages such as shorter hospital stays and accelerated recovery times.

Despite these growth drivers, the market encounters significant hurdles related to strict reimbursement protocols and the substantial costs of procedures, which limit patient access in economically constrained healthcare environments. The International Osteoporosis Foundation noted in 2024 that up to 37 million fragility fractures occur annually in individuals over the age of 55, underscoring a massive clinical need for fracture management solutions. However, even with this high incidence rate, financial barriers and coverage restrictions continue to pose significant obstacles to broader market development and expansion.

Market Drivers

Technological advancements in kyphoplasty systems and bone cements are significantly propelling market growth by improving procedural safety and clinical results. Manufacturers are increasingly focusing on developing high-viscosity cements and advanced balloon catheters that minimize leakage risks while ensuring precise vertebral height restoration, thereby boosting surgeon confidence and adoption. Furthermore, the integration of radiofrequency-targeted augmentation and steerable balloons has optimized surgical workflows, making these minimally invasive interventions more appealing than traditional methods. This demand is reflected in Stryker's February 2025 report, which noted that their Interventional Spine business achieved over 10% organic sales growth in 2024, driven by the strong uptake of these specialized spine technologies.

Simultaneously, the rising prevalence of osteoporosis and vertebral compression fractures acts as a fundamental catalyst for global market expansion. As the population ages, low-bone-density conditions become more common, resulting in a larger pool of patients susceptible to fragility fractures that require surgical stabilization. The U.S. Preventive Services Task Force highlighted in January 2025 that osteoporosis affects 27.1% of women aged 65 and older, a statistic that correlates directly with increased procedural volumes as providers prioritize early intervention. This demand contributes to sector financial health, as evidenced by Merit Medical Systems reporting a 2024 annual revenue of $1.357 billion, a 7.9% year-over-year increase largely supported by its interventional device portfolio.

Market Challenges

Stringent reimbursement policies and high procedural costs constitute substantial barriers to the growth of the kyphoplasty market. Healthcare providers frequently face complicated approval processes and declining payment rates for vertebral augmentation, which discourages the widespread adoption of these treatments in cost-conscious settings. When insurance coverage is restricted or denied, the financial burden often shifts to medical facilities or patients, leading to a decline in elective procedure volumes. Consequently, economic pressures force hospitals to favor conservative management options, such as bed rest and pain medication, rather than utilizing minimally invasive surgical interventions.

These financial constraints are intensifying across major healthcare systems, directly impacting the profitability and viability of offering specialized spinal surgeries. In 2024, the American Medical Association reported a 3.39 percent reduction in Medicare physician payment rates, which further compresses operating margins for practices performing kyphoplasty. Such fiscal tightening limits the ability of healthcare providers to invest in necessary equipment and reduces patient access to advanced care. As a result, valid clinical candidates are often diverted toward lower-cost therapies, directly impeding total market revenue growth.

Market Trends

The migration of vertebral augmentation procedures to Ambulatory Surgical Centers (ASCs) represents a significant structural shift driven by the demand for cost-effective outpatient care. Because kyphoplasty is a minimally invasive procedure, payers are actively moving these cases from traditional hospitals to specialized facilities to lower overhead costs and improve patient throughput. This transition is supported by the operational efficiency of ASCs, which allow for higher case volumes and expedited discharge processes. The financial success of this trend is illustrated by Surgery Partners, which reported in March 2025 a total annual revenue of $3.1 billion for 2024, a 13.5% increase year-over-year attributed to the strategic expansion of short-stay surgical facilities.

Concurrently, the incorporation of intraoperative 3D fluoroscopy and navigation technologies is redefining procedural standards by addressing the critical need for precision during cement delivery. Unlike standard 2D imaging, these advanced systems provide real-time, multi-dimensional visualization of vertebral anatomy, significantly reducing the risk of cement leakage and lowering radiation exposure for the surgical team. This technological integration enhances clinical confidence in treating complex fractures, promoting broader utilization of augmentation therapies. In February 2025, Medtronic reported that its Cranial and Spinal Technologies division generated $1.25 billion in revenue, a 3.8% year-over-year increase driven primarily by the robust adoption of its enabling technology ecosystem.

Key Players Profiled in the Kyphoplasty Market

• Stryker Corporation
• Medtronic PLC
• Smith + Nephew PLC
• Microport Scientific Corporation
• DePuy Synthes Companies
• IZI Medical Products, LLC (Halma PLC)
• Merit Medical Systems, Inc.
• Joline GmbH & Co. KG
• Hensler Surgical Products LLC
• Jiangsu Changmei Medtech Co., Ltd.

Report Scope

In this report, the Global Kyphoplasty Market has been segmented into the following categories:

Kyphoplasty Market, by Product:

• Balloon Catheters
• Bone Access Devices
• Cement Application Products
• Bone Cement
• Cement Mixing System
• Instruments

Kyphoplasty Market, by Application:

• Vertebral Alignment Restoration
• Spinal Fractures
• Kyphosis

Kyphoplasty Market, by Indication:

• Osteoporosis
• Others

Kyphoplasty Market, by End User:

• Hospitals & Clinics
• Ambulatory Surgical Centres
• Others

Kyphoplasty Market, by Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Kyphoplasty Market.

Available Customization

The analyst offers customization according to your specific needs. The following customization options are available for the report:

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.